This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
To identify APOC3 455 T/C polymorphism in metabolic syndrome subjects. Fifty control subjects without metabolic syndrome
(MetS) and fifty patients with MetS using IDF 2005 criteria were identified. MetS was diagnosed on the presence of waist
circumference (WC) (men≥ 90cm, women ≥ 80 cm) plus any two of the following four factors; (I) triglycerides (TG) >150mg/
dl (1.7mmol/l),(II) HDL-cholesterol (HDL-C) < 40 mg/dl(1.0mmol/l) for men, < 50 mg/dl(1.3mmol/l) for women, (III) fasting
plasma glucose (FPG) ≥ 100mg/dl (6.1mmol/l) and (IV) blood pressure (BP) ≥ 130/85mm of Hg. Genotyping for APOC3 455
T/C polymorphism was done by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method.
In the study group (50 patients with MetS) the wild type (normal) 455 T/T was present in 22%; the heterozygous mutant 455 C/T
was present in 78%. In the control group (50 controls without MetS ) the wild type (normal) APOC3 455 T/T was present in 26%;
the heterozygous mutant 455 C/T was present in 74%. (P>0.05, NS). APOC3 455 T/C polymorphism may not be a predictor of
metabolic syndrome in a significant manner. Studies in larger populations and correlations with data of other studies is required.
Dr Pemminati Sudhakar has completed his Ph.D at the age of 30 years from Kasturba Medical College, Manipal University. He is the Ast Professor
of Pharmacology, Kasturba Medical College, Mangalore. He has published more than 30 papers in reputed journals and serving as an editorial board
member of repute. He has received two gold medals and various awards.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals